

RadioSyn
RadioSyn is designing and manufacturing a miniaturized automated radiopharmaceutical synthesis platform. We deliver a shielded, state-of-the-art synthesizer that eliminates traditional production barriers and complexity. Our automated synthesis technology platform addresses critical limitations in conventional diagnostic and therapeutic workflows by standardizing and streamlining radioimmunoconjugate and radiopharmaceutical manufacturing.
Our Platform

Our platform uses disposable microfluidic chips that perform end-to-end chemical and radiochemical reactions. The Radiosyn platform offers reproducible, high-quality radiopharmaceutical production across research and clinical settings, requiring minimal specialized radiochemistry expertise. The device offers cost-effective, on-demand delivery of radiopharmaceuticals, making it ideal for meeting the growing demand for personalized and precision medicine. Our mission is to accelerate scientific discovery and clinical use of radiopharmaceuticals by making their production more accessible, standardized, and scalable.
Our Team

Dr. Sam Sadeghi
CEO, Co-founder
Radiochemistry expert focused on business development and market positioning

Xueyi Wang
CSO, Co-founder
Radiochemistry Lead

Matthew McLennan
Automation Engineer
.jpg)
Ali Mohammadi
Microfluidic Engineer

Dr. Ravi Selvaganapathy
CTO, Co-founder
Biomedical engineering expert focused on project management and business development

Shayan Jahangirifard
COO, Co-founder
Engineering Lead

Clara Jonkman
Microfluidic Engineer
.jpg)
Stefano Biasi
Radiochemist
.jpeg)
Shereecia Bangura
Research Assistant
Our Partners

